Skip to main content

Dexcom Inc(DXCM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low65.79
Day High67.98
Open:67.11
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Dexcom Inc

Select a category then submit the form to load news
Motley Fool
2 Growth Stocks to Hold for the Next Decade
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Dexcom (DXCM), Medline (MDLN)
StockStory
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
TECH
Tipranks
Dexcom Executive Chairman Kevin Sayer Returns From Leave
Tipranks
Jefferies Sticks to Their Buy Rating for Dexcom (DXCM)
Tipranks
Dexcom Adds Google Executive Rick Osterloh to Board
Motley Fool
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
Tipranks
BTIG Reaffirms Their Buy Rating on Dexcom (DXCM)
StockStory
The 5 Most Interesting Analyst Questions From DexCom’s Q4 Earnings Call
DXCM
Tipranks
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Neurocrine (NBIX) and Dexcom (DXCM)
Tipranks
Dexcom’s $750 Million 2025 Buyback Plan Faces Uncertain Execution and Limited Assurance of Shareholder Value
Tipranks
DexCom Earnings Call Highlights Margin Rebound, Growth
Tipranks
Dexcom (DXCM) Gets a Buy from Jefferies
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurocrine (NBIX), Dexcom (DXCM) and Icon (ICLR)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: PolyPid (PYPD), Dexcom (DXCM)
Tipranks
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), American Well (AMWL) and Avita Medical (RCEL)
Tipranks
Morgan Stanley Sticks to Its Buy Rating for Dexcom (DXCM)
Tipranks
Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Vertex Pharmaceuticals (VRTX) and Royalty Pharma (RPRX)
Tipranks
Analysts Conflicted on These Healthcare Names: Rezolute (RZLT), Dexcom (DXCM) and Bruker (BRKR)
Stock Target Advisor
CPI Reduction Calms Inflation Fears-Market Analysis for February 13th, 2026
CPI Reduction Calms Inflation Fears-Market Analysis for February 13th, 2026
StockStory
Why Is DexCom (DXCM) Stock Rocketing Higher Today
DXCM
Motley Fool
Soleus Adds a Significant Number of Celcuity Shares
StockStory
DXCM Q4 Deep Dive: New Product Launches and International Strategy Drive Outlook
DXCM
Motley Fool
DexCom (DXCM) Q4 2025 Earnings Call Transcript
StockStory
DexCom (NASDAQ:DXCM) Exceeds Q4 CY2025 Expectations
DXCM
Zacks Investment Research
Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM
Medical Device Stocks to Report Earnings on Feb. 12: BAX, WST & DXCM
StockStory
Earnings To Watch: DexCom (DXCM) Reports Q4 Results Tomorrow
DXCM
StockStory
1 High-Flying Stock with Impressive Fundamentals and 2 We Ignore
FORM
StockStory
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
KLIC
StockStory
3 Profitable Stocks for Long-Term Investors
RBC
StockStory
2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore
GWRE
Zacks Investment Research
Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?
Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?

Profile

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.